PODCAST

Urology

ReachMD

science & medicine medicine

All Episodes

00:00:00

Advancing Care in Non-Clear Cell RCC: Optimizing ICI...

Urology ·

2025/05/09

Guest: Pedro Barata, MD, MSc, FACP Guest: Sumanta K. Pal, MD, FASCO Stay at the forefront of nccRCC care by exploring the latest advances in treatment strategies. Gain key insights into optimizing patient selection, enhancing diagnostic accuracy, and managing adverse events to improve patient outcomes. This comprehensive activity delves into emerging data, the rationale for ICI/TKI combination therapy, the latest clinical trial findings, and best practices for treatment sequencing

00:00:00

Antibody-Drug Conjugates in Bladder Cancer: Guideline...

Urology ·

2025/03/26

Host: Elizabeth R. Plimack, MD, MS, FASCO Guest: Shilpa Gupta, MD New understanding of molecular targets has helped transform invasive bladder cancer treatment, and guidelines now recommend chemotherapy-free immunotherapy as first-line treatment for metastatic bladder cancer (mBC), with additional studies investigating its role in neoadjuvant and adjuvant treatments for muscle-invasive bladder cancer (MIBC). These newer immunotherapy treatments, however, can cause unique, sometimes

00:00:00

What Can I Do to Improve Care of Prostate Cancer...

Urology ·

2023/09/29

Host: Kelvin A. Moses, MD, PhD, FACS This program increases awareness of androgen deprivation therapy (ADT) as a mainstay of treating patients with metastatic hormone-sensitive prostate cancer (mHSPC) and leads to new opportunities to improve patient care. Recent developments create a need for a greater understanding of practice-changing clinical trial data and guideline recommendations to treat patients with mHSPC.This program provides information on the most effective implementation

00:00:00

Expert Panel: Selecting Treatment in mHSPC: Which...

Urology ·

2023/09/29

Host: Kelvin A. Moses, MD, PhD, FACS Host: Alicia K. Morgans, MD, MPH This program increases awareness of androgen deprivation therapy (ADT) as a mainstay of treating patients with metastatic hormone-sensitive prostate cancer (mHSPC) and leads to new opportunities to improve patient care. Recent developments create a need for a greater understanding of practice-changing clinical trial data and guideline recommendations to treat patients with mHSPC.This program provides information

00:00:00

Expert Panel: How Can We Integrate Patient Preference...

Urology ·

2023/09/29

Host: Alicia K. Morgans, MD, MPH Host: Kelvin A. Moses, MD, PhD, FACS This program increases awareness of androgen deprivation therapy (ADT) as a mainstay of treating patients with metastatic hormone-sensitive prostate cancer (mHSPC) and leads to new opportunities to improve patient care. Recent developments create a need for a greater understanding of practice-changing clinical trial data and guideline recommendations to treat patients with mHSPC.This program provides information

00:00:00

What Is the Pharmacist’s Role in Managing mHSPC...

Urology ·

2023/09/29

Host: Lisa Holle, PharmD, BCOP, FHOPA, FISOPP This program increases awareness of androgen deprivation therapy (ADT) as a mainstay of treating patients with metastatic hormone-sensitive prostate cancer (mHSPC) and leads to new opportunities to improve patient care. Recent developments create a need for a greater understanding of practice-changing clinical trial data and guideline recommendations to treat patients with mHSPC.This program provides information on the most effective

00:00:00

What Is the Current State of Disparities in Prostate...

Urology ·

2023/09/29

00:00:00

How Nurses and Advanced Practice Clinicians Can Help...

Urology ·

2023/09/29

Host: Stacy Walker, NP This program increases awareness of androgen deprivation therapy (ADT) as a mainstay of treating patients with metastatic hormone-sensitive prostate cancer (mHSPC) and leads to new opportunities to improve patient care. Recent developments create a need for a greater understanding of practice-changing clinical trial data and guideline recommendations to treat patients with mHSPC.This program provides information on the most effective implementation of androgen

00:00:00

Expert Panel: How Does ADT Intensification for mHSPC...

Urology ·

2023/09/29

00:00:00

Choosing Between Doublets and Triplets in mHSPC: What...

Urology ·

2023/09/29

Host: Alicia K. Morgans, MD, MPHThis program increases awareness of androgen deprivation therapy (ADT) as a mainstay of treating patients with metastatic hormone-sensitive prostate cancer (mHSPC) and leads to new opportunities to improve patient care. Recent developments create a need for a greater understanding of practice-changing clinical trial data and guideline recommendations to treat patients with mHSPC.This program provides information on the most effective implementation of

00:00:00

Case Study: How Do We Optimize Treatment Adherence...

Urology ·

2023/08/18

Host: Rana McKay, MD Host: Neeraj Agarwal, MD, FASCO Patients with high-risk, localized prostate cancer have an increased risk of developing metastases and experiencing prostate cancer-specific death compared to those with low- and intermediate-risk disease. The results of the STAMPEDE trial changed the standard of care for these patients, improving survival endpoints by intensifying androgen deprivation therapy (ADT) with the addition of abiraterone. Given the STAMPEDE data and

00:00:00

How Do We Identify Patients with Localized Prostate...

Urology ·

2023/08/18

Host: Rana McKay, MD Patients with high-risk, localized prostate cancer have an increased risk of developing metastases and experiencing prostate cancer-specific death compared to those with low- and intermediate-risk disease. The results of the STAMPEDE trial changed the standard of care for these patients, improving survival endpoints by intensifying androgen deprivation therapy (ADT) with the addition of abiraterone. Given the STAMPEDE data and the benefit of other second-generation

00:00:00

How Are ARIs Being Used to Intensify Therapy for...

Urology ·

2023/08/18

00:00:00

Expert Panel: What Is the Future of Early...

Urology ·

2023/08/18

00:00:00

Can ARIs Be Combined with Radiation Therapy in...

Urology ·

2023/08/18

Host: Neeraj Agarwal, MD, FASCO Patients with high-risk, localized prostate cancer have an increased risk of developing metastases and experiencing prostate cancer-specific death compared to those with low- and intermediate-risk disease. The results of the STAMPEDE trial changed the standard of care for these patients, improving survival endpoints by intensifying androgen deprivation therapy (ADT) with the addition of abiraterone. Given the STAMPEDE data and the benefit of other

00:00:00

What Is the Future of Neoadjuvant ARI Intensification...

Urology ·

2023/08/18

00:00:00

Should We Make Active Surveillance More Active for...

Urology ·

2023/08/18

00:00:00

Optimizing the Use of Immunotherapy in the First-line...

Urology ·

2023/07/19

Guest: Petros Grivas, MD, PhD Guest: Thomas Powles, MD, PhD Survival for patients with metastatic urothelial cancer has increased with the approval of immune therapy, antibody-drug conjugates, and targeted agents. In the maintenance setting, avelumab has become the global standard of care. Do you know how to evaluate and effectively implement immune therapy in the maintenance setting in your practice?

00:00:00

Understanding the Biological and Clinical Rationale...

Urology ·

2023/06/29

Host: Neeraj Agarwal, MD, FASCO Prostate cancer is a disease characterized by high genomic instability. Prostate cancers with deleterious aberrations in DNA damage repair (DDR) genes, including homologous recombination repair (HRR), such as mutations in BRCA1/2 and ATM, are associated with response to poly(adenosine diphosphate–ribose) polymerase (PARP) inhibition. The US Food and Drug Administration (FDA) has approved PARP inhibitors as monotherapy for the treatment of previously

00:00:00

A Wee History Lesson on Uroscopy

Urology ·

2023/03/24

Host: Marshall Miller Relieve yourself of any curiosity surrounding the history of uroscopy with our whiz-bang host Marshall Miller.

80 results

Urology

All Episodes

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事